• Home
  • Screening services

Screening services

At Xyla, we deliver high-quality, patient-centred screening services designed to identify serious health conditions at their earliest and most treatable stages. Our nurse-led, technology-enabled approach ensures that every individual receives compassionate care in a way that’s accessible, inclusive and tailored to their needs.   

Why Xyla

Clinically robust & trusted 
  • CQC registered provider
  • Working with over 80 NHS trusts and ICSs
  • Clinically focused, with a Medical Advisory Board for each specialty
Inclusive & equitable care 

We specialise in reaching underserved groups, including:

  • Ethnic minorities, homeless populations, and traveller communities
  • People with disabilities, low literacy, or digital exclusion
  • Those in rural or deprived areas
Technology-enabled & patient-focused 
  • Secure data systems (SystmOne) linked to the NHS spine
  • Self-booking tools, SMS reminders and multi-channel communication
  • Real-time dashboards for commissioners and partners
  • Intelligent, insight-driven contact strategies to reduce DNAs and improve uptake
Commercially viable & scalable 
  • Outcome-based pricing model with transparent unit rates
  • Proven conversion rates and scanner utilisation above national targets
  • Scalable workforce and infrastructure to support national programmes

Our screening services

Lung cancer screening  

Lung cancer screening is essential for detecting cancer early, when treatment is most effective. By bringing diagnostics closer to patients, we improve access to these vital screening services.

Integrating workforce, technology, and clinical governance we deliver a safe, high-quality Lung Cancer Screening experience.

Workforce 

We provide trained nursing and administrative staff to support:

  • Virtual health checks
  • Post-scan follow-up
  • Multidisciplinary team (MDT) collaboration
  • Data management

Technology 

  • Our solution is built around a secure SystmOne platform, integrated with the NHS Spine, ensuring a reliable and seamless patient pathway.
  • Data-driven tools enhance user engagement and streamline service delivery.

Our full screening services  

Alongside Lung Cancer Screening, we also provide screening in the following areas:  

  • Abdominal Aortic Aneurysm (AAA) screening 
  • Bowel cancer screening 
  • Breast cancer screening 
  • Cervical cancer screening  

Clinical governance 

Our approach aligns with your governance standards, helping to: 

  • Improve patient experience 
  • Boost productivity 
  • Ensure safety across the care pathway 

Regulatory compliance 

As a CQC-registered provider, we meet the required standards for quality and safety in healthcare delivery.

Aligning with your governance standards to improving patient experience, boosting productivity, and ensuring safety. 

Outcomes

Over 60% of referrals from GPs complete a lung cancer screening

DNS rate of below 7% 

97% patient satisfaction 

30% increase in patient contact rates

Find out more about our recent Lung Cancer Screening programme for South Yorkshire and Bassetlaw Cancer Alliance.

Are you on our Lung Cancer Screening programme?

Please click here if you are

Contact us

Fields marked with an * are required.

Xyla is a trading name of ICS Operations Ltd (Registered No 4793945), Pulse Healthcare Limited (Registered No 3156103), Carehome Selection Limited (Registered No 3091598), Independent Clinical Services Limited (Registered No 4768329) and CHS Healthcare Software Limited (Registered No 11582111)